| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 AND BMP4 ON THE HYPOXIC INDUCTION OF CYCLOOXYGENASE-2 IN HUMAN PULMONARY ARTERY SMOOTH MUSCLE CELLS
1 Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, Cambridgeshire, United Kingdom
* To whom correspondence should be addressed. E-mail: nwm23{at}cam.ac.uk.
Chronic hypoxia-induced pulmonary hypertension results partly from proliferation of smooth muscle cells in small peripheral pulmonary arteries. Previously we demonstrated
that hypoxia modulates the proliferation of human peripheral pulmonary artery smooth muscle cells (PASMCs) by induction of cyclooxygenase-2 (COX-2) and production of
antiproliferative prostaglandins. The TGF-
superfamily plays a critical role in the regulation of pulmonary vascular remodeling, though to date an interaction with hypoxia has not been examined. We therefore investigated the pathways involved in the hypoxic
induction of COX-2 in peripheral PASMCs and the contribution of TGF-1 and BMP4 in
this response. In the present study we demonstrate that hypoxia induces activation of p38MAPK, ERK1/2 and Akt in PASMCs and that these pathways are involved in the hypoxic regulation of COX-2. Whereas inhibition of p38MAPK or ERK1/2 activity suppressed hypoxic induction of COX-2, inhibition of the phosphoinositide-3-kinase pathway enhanced hypoxic induction of COX-2. Furthermore, exogenous TGF-1 induced COX-2 mRNA and protein expression, and our findings demonstrate that release of TGF-1 by PASMCs during hypoxia contributes to the hypoxic induction of COX-2
via the p38MAPK pathway. In contrast, BMP4 inhibited the hypoxic-induction of COX-2 by a MAPK- independent pathway. Taken together, these findings suggest that the TGF- superfamily are part of an autocrine/paracrine system involved in the regulation of
COX-2 expression in the distal pulmonary circulation and this modulates hypoxiainduced pulmonary vascular cell proliferation.
This article has been cited by other articles:
|
|
 |
|
  L. De Franceschi, O. S. Platt, G. Malpeli, A. Janin, A. Scarpa, C. Leboeuf, Y. Beuzard, E. Payen, and C. Brugnara Protective effects of phosphodiesterase-4 (PDE-4) inhibition in the early phase of pulmonary arterial hypertension in transgenic sickle cell mice FASEB J, June 1, 2008; 22(6): 1849 - 1860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Zaiman, M. Podowski, S. Medicherla, K. Gordy, F. Xu, L. Zhen, L. A. Shimoda, E. Neptune, L. Higgins, A. Murphy, et al. Role of the TGF-{beta}/Alk5 Signaling Pathway in Monocrotaline-induced Pulmonary Hypertension Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 896 - 905. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Newman, J. A. Phillips III, and J. E. Loyd Narrative Review: The Enigma of Pulmonary Arterial Hypertension: New Insights from Genetic Studies Ann Intern Med, February 19, 2008; 148(4): 278 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Yang, P. J. Lee, L. Long, R. C. Trembath, and N. W. Morrell BMP4 Induces HO-1 via a Smad-Independent, p38MAPK-Dependent Pathway in Pulmonary Artery Myocytes Am. J. Respir. Cell Mol. Biol., November 1, 2007; 37(5): 598 - 605. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Sanders and J. R. Hoidal The NOX on Pulmonary Hypertension Circ. Res., August 3, 2007; 101(3): 224 - 226. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Aoki, H. Ohnishi, K. Hama, S. Shinozaki, H. Kita, H. Osawa, H. Yamamoto, K. Sato, K. Tamada, and K. Sugano Cyclooxygenase-2 is required for activated pancreatic stellate cells to respond to proinflammatory cytokines Am J Physiol Cell Physiol, January 1, 2007; 292(1): C259 - C268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. W. Morrell Pulmonary Hypertension Due to BMPR2 Mutation: A New Paradigm for Tissue Remodeling? Proceedings of the ATS, November 1, 2006; 3(8): 680 - 686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Fantozzi, O. Platoshyn, A. H. Wong, S. Zhang, C. V. Remillard, M. R. Furtado, O. V. Petrauskene, and J. X.-J. Yuan Bone morphogenetic protein-2 upregulates expression and function of voltage-gated K+ channels in human pulmonary artery smooth muscle cells Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L993 - L1004. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wu, M. S. Chang, S. A. Mitsialis, and S. Kourembanas Hypoxia Regulates Bone Morphogenetic Protein Signaling Through C-Terminal-Binding Protein 1 Circ. Res., August 4, 2006; 99(3): 240 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sturrock, B. Cahill, K. Norman, T. P. Huecksteadt, K. Hill, K. Sanders, S. V. Karwande, J. C. Stringham, D. A. Bull, M. Gleich, et al. Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells Am J Physiol Lung Cell Mol Physiol, April 1, 2006; 290(4): L661 - L673. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-F. Chen, J.-A. Feng, P. Li, D. Xing, Y. Zhang, R. Serra, N. Ambalavanan, E. Majid-Hassan, and S. Oparil Dominant negative mutation of the TGF-beta receptor blocks hypoxia-induced pulmonary vascular remodeling J Appl Physiol, February 1, 2006; 100(2): 564 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Frank, A. Abtahi, D.J. Yamaguchi, S. Manning, Y. Shyr, A. Pozzi, H. S. Baldwin, J. E. Johnson, and M. P. de Caestecker Bone Morphogenetic Protein 4 Promotes Pulmonary Vascular Remodeling in Hypoxic Pulmonary Hypertension Circ. Res., September 2, 2005; 97(5): 496 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Lepetit, S. Eddahibi, E. Fadel, E. Frisdal, C. Munaut, A. Noel, M. Humbert, S. Adnot, M-P. D'Ortho, and C. Lafuma Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension Eur. Respir. J., May 1, 2005; 25(5): 834 - 842. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
